Zhu Q - Search Results

1

YL064 activates proteasomal-dependent degradation of c-Myc and synergistically enhances the anti-tumor activity of ABT-199 in diffuse large B cell lymphoma.

Shan H, Cao Y, Xiao X, Liu M, Wu Y, Zhu Q, Xu H, Lei H, Yao Z, Wu Y. Shan H, et al. Among authors: zhu q. Signal Transduct Target Ther. 2020 Jul 6;5(1):116. doi: 10.1038/s41392-020-00236-1. Signal Transduct Target Ther. 2020. PMID: 32632092 Free PMC article. No abstract available.

2

cAMP induces cell apoptosis in multiple myeloma and overcomes bortezomib resistance.

Wang Y, Tang Y, Hang H, Wang M, Pang Y, Yu Y, Wu Y, Zhu Q. Wang Y, et al. Among authors: zhu q. Am J Cancer Res. 2018 Jan 1;8(1):16-29. eCollection 2018. Am J Cancer Res. 2018. PMID: 29416917 Free PMC article.

3

YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells.

Wang Y, Wu L, Cai H, Lei H, Ma CM, Yang L, Xu H, Zhu Q, Yao Z, Wu Y. Wang Y, et al. Among authors: zhu q. Cell Death Discov. 2018 Oct 3;4:44. doi: 10.1038/s41420-018-0108-8. eCollection 2018. Cell Death Discov. 2018. PMID: 30302278 Free PMC article.

4

Sinomenine derivative YL064: a novel STAT3 inhibitor with promising anti-myeloma activity.

Wang Y, Wu L, Cai H, Lei H, Ma CM, Yang L, Xu H, Zhu Q, Yao Z, Wu Y. Wang Y, et al. Among authors: zhu q. Cell Death Dis. 2018 Oct 25;9(11):1093. doi: 10.1038/s41419-018-1147-z. Cell Death Dis. 2018. PMID: 30361529 Free PMC article. No abstract available.

5

Targeting USP9x/SOX2 axis contributes to the anti-osteosarcoma effect of neogambogic acid.

Chen X, Zhang X, Cai H, Yang W, Lei H, Xu H, Wang W, Zhu Q, Kang J, Yin T, Gu W, Wu YL. Chen X, et al. Among authors: zhu q. Cancer Lett. 2020 Jan 28;469:277-286. doi: 10.1016/j.canlet.2019.10.015. Epub 2019 Oct 9. Cancer Lett. 2020. PMID: 31605775

6

Ubiquitin-specific protease 14 targets PFKL-mediated glycolysis to promote the proliferation and migration of oral squamous cell carcinoma.

Zhang X, Geng L, Tang Y, Wang Y, Zhang Y, Zhu C, Lei H, Xu H, Zhu Q, Wu Y, Gu W. Zhang X, et al. Among authors: zhu q, zhu c. J Transl Med. 2024 Feb 22;22(1):193. doi: 10.1186/s12967-024-04943-z. J Transl Med. 2024. PMID: 38388430 Free PMC article.

7

The prognostic value of immunohistochemical subtyping in Chinese patients with de novo diffuse large B-cell lymphoma undergoing CHOP or R-CHOP treatment.

Xia ZG, Xu ZZ, Zhao WL, Zhao SQ, Ding F, Chen Y, Chen QS, Zheng Y, Zhu Q, Hu JP, Shen ZX, Li JM. Xia ZG, et al. Among authors: zhu q. Ann Hematol. 2010 Feb;89(2):171-7. doi: 10.1007/s00277-009-0799-2. Epub 2009 Aug 11. Ann Hematol. 2010. PMID: 19669764

8

Outcomes in refractory diffuse large B-cell lymphoma: results from a multicenter real-world study in China.

Wang S, Wang L, Hu J, Qian W, Zhang X, Hu Y, Zhu Q, Chen B, Wu D, Chang CH, Xu P, Zheng X, Wei J, Liu Y, Cui G, Tang Y, Ma Y, Huang H, Yi H, Zhao W. Wang S, et al. Among authors: zhu q. Cancer Commun (Lond). 2021 Mar;41(3):229-239. doi: 10.1002/cac2.12126. Epub 2021 Jan 22. Cancer Commun (Lond). 2021. PMID: 33482051 Free PMC article.

9

Anterior gradient 2 is a binding stabilizer of hypoxia inducible factor-1α that enhances CoCl2 -induced doxorubicin resistance in breast cancer cells.

Li Z, Zhu Q, Hu L, Chen H, Wu Z, Li D. Li Z, et al. Among authors: zhu q. Cancer Sci. 2015 Aug;106(8):1041-9. doi: 10.1111/cas.12714. Epub 2015 Jul 17. Cancer Sci. 2015. PMID: 26079208 Free PMC article.

10

[Correlation of cell cycle alteration to SOCS-1 gene demethylation induced by arsenic trioxide in myeloma cell lines].

Wang MM, Dou HJ, Zou LF, Zhu Q, Ren ZH, Hu JP. Wang MM, et al. Among authors: zhu q. Ai Zheng. 2008 Nov;27(11):1150-4. Ai Zheng. 2008. PMID: 19000444 Free article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,228 results

Search Page

Filters